Neoadjuvant systemic treatment of breast cancer

Apparent Diffusion Coefficient Values for Discriminating Benign and Malignant Breast MRI Lesions: Effects of Lesion Type and Size

(2010) Savannah C. Partridge et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

MRI-Model to Guide the Surgical Treatment in Breast Cancer Patients After Neoadjuvant Chemotherapy

(2010) Marieke E. Straver et al.   ANNALS OF SURGERY

Locoregional treatment of primary breast cancer

(2010) Manfred Kaufmann et al.   CANCER

Inflammatory Breast Cancer: Novel Preoperative Therapies

(2010) Beth A. Overmoyer   Clinical Breast Cancer

Capecitabine in Addition to Anthracycline- and Taxane-Based Neoadjuvant Treatment in Patients With Primary Breast Cancer: Phase III GeparQuattro Study

(2010) Gunter von Minckwitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study

(2010) Michael Untch et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer

(2010) Abigail S. Caudle et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast Cancer Among the Oldest Old: Tumor Characteristics, Treatment Choices, and Survival

(2010) Mara A. Schonberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant therapy for breast cancer

(2010) Stephen V. Liu et al.   JOURNAL OF SURGICAL ONCOLOGY

Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer-clinical examination, mammography, or magnetic resonance imaging?

(2010) F.C. Wright et al.   JOURNAL OF SURGICAL ONCOLOGY

Increasing Accuracy of Detection of Breast Cancer with 3-T MRI

(2009) Haitham Elsamaloty et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Prognostic Impact of [18F] FDG-PET in Operable Breast Cancer Treated with Neoadjuvant Chemotherapy

(2009) So-Youn Jung et al.   ANNALS OF SURGICAL ONCOLOGY

Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer

(2009) Robin L. Jones et al.   BREAST CANCER RESEARCH AND TREATMENT

Target-based therapies in breast cancer: current status and future perspectives

(2009) Nicola Normanno et al.   ENDOCRINE-RELATED CANCER

Frequent Pathologic Complete Responses in Aggressive Stages II to III Breast Cancers With Every-4-Week Carboplatin and Weekly Paclitaxel With or Without Trastuzumab: A Brown University Oncology Group Study

(2009) William M. Sikov et al.   JOURNAL OF CLINICAL ONCOLOGY

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

(2009) C. J. Creighton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Staging of Breast Cancer in the Neoadjuvant Setting

(2008) J. S. Jeruss et al.   CANCER RESEARCH

Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

(2008) Priya Rastogi et al.   JOURNAL OF CLINICAL ONCOLOGY

Is There a Role for Positron Emission Tomography in Breast Cancer Staging?

(2008) Nicole C. Hodgson et al.   JOURNAL OF CLINICAL ONCOLOGY

Statement of the Science Concerning Locoregional Treatments After Preoperative Chemotherapy for Breast Cancer: A National Cancer Institute Conference

(2008) Thomas A. Buchholz et al.   JOURNAL OF CLINICAL ONCOLOGY

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study

(2008) Jean-Marc Classe et al.   JOURNAL OF CLINICAL ONCOLOGY

Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio Study

(2008) G. von Minckwitz et al.   JNCI-Journal of the National Cancer Institute

Neoadjuvant Vinorelbine-Capecitabine Versus Docetaxel-Doxorubicin-Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial

(2008) G. von Minckwitz et al.   JNCI-Journal of the National Cancer Institute

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

(2008) X. Li et al.   JNCI-Journal of the National Cancer Institute

Prognostic Value of Initial Clinical Disease Stage After Achieving Pathological Complete Response

(2008) S. Dawood et al.   ONCOLOGIST

Presurgical Systemic Treatment of Nonmetastatic Breast Cancer: Facts and Open Questions

(2008) A. Berruti et al.   ONCOLOGIST